Literature DB >> 8703876

Progression of disease in ocular cicatricial pemphigoid.

M J Elder1, W Bernauer, J Leonard, J K Dart.   

Abstract

BACKGROUND: Ocular cicatricial pemphigoid (OCP) is a sight threatening autoimmune disease that can lead to severe conjunctival cicatrisation and keratopathy. It has a variable course and little is known about the factors that determine disease progression. This study analysed the factors that have prognostic significance regarding disease outcome, progression, and keratopathy.
METHODS: Sixty six patients with OCP were monitored prospectively at Moorfields Eye Hospital. The influence of ocular features, the systemic disease, and the management were analysed to identify factors that influence the outcomes and disease progression.
RESULTS: The mean age at presentation was 67 years; 56% were men. The binocular visual acuities were 6/24 or worse in 25%. Extensive cicatrisation at presentation was common but correlated only weakly with the visual prognosis. Systemic manifestations included lesions of the mouth in 44%, pharynx in 30%, oesophagus in 27%, nose/sinus in 18%, and skin in 17%. There was no association between the ocular and systemic manifestations. Persistent corneal epithelial defects and limbitis occurred in 18% and 32%, respectively, and both were associated with a worse visual prognosis. Systemic immunosuppression was ultimately prescribed in 74%, mainly in patients with advanced stages of conjunctival cicatrisation. Of patients with more than 24 months follow up, progression of cicatrisation occurred in 35% of eyes (16/46) all but one of which were associated with episodes of conjunctival inflammation.
CONCLUSIONS: Persistent epithelial defects, limbal inflammation, and ongoing conjunctival inflammation are important factors that lead to keratopathy and visual handicap. These require aggressive management, often with systemic immunosuppressive treatment. Close follow up is required in cases with extensive cicatrisation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8703876      PMCID: PMC505451          DOI: 10.1136/bjo.80.4.292

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  15 in total

1.  Corneal infection in mucosal scarring disorders and Sjögren's syndrome.

Authors:  L D Ormerod; L P Fong; C S Foster
Journal:  Am J Ophthalmol       Date:  1988-05-15       Impact factor: 5.258

2.  Cicatricial pemphigoid.

Authors:  C S Foster
Journal:  Trans Am Ophthalmol Soc       Date:  1986

Review 3.  Pemphigus and pemphigoid. A review of the advances made since 1964.

Authors:  W F Lever
Journal:  J Am Acad Dermatol       Date:  1979-07       Impact factor: 11.527

4.  Benign mucous membrane pemphigoid.

Authors:  K M Hardy; H O Perry; G C Pingree; T J Kirby
Journal:  Arch Dermatol       Date:  1971-11

5.  Ocular cicatricial pemphigoid.

Authors:  B J Mondino; S I Brown
Journal:  Ophthalmology       Date:  1981-02       Impact factor: 12.079

6.  Immunophenotypic analysis of the inflammatory infiltrate in ocular cicatricial pemphigoid. Further evidence for a T cell-mediated disease.

Authors:  E H Sacks; F A Jakobiec; R Wieczorek; E Donnenfeld; H Perry; D M Knowles
Journal:  Ophthalmology       Date:  1989-02       Impact factor: 12.079

7.  Immunosuppressive therapy for progressive ocular cicatricial pemphigoid.

Authors:  C S Foster; L A Wilson; M B Ekins
Journal:  Ophthalmology       Date:  1982-04       Impact factor: 12.079

8.  Role of cyclophosphamide and high dose steroid in ocular cicatricial pemphigoid.

Authors:  M J Elder; S Lightman; J K Dart
Journal:  Br J Ophthalmol       Date:  1995-03       Impact factor: 4.638

9.  Immunofluorescent studies in ocular cicatricial pemphigoid.

Authors:  J N Leonard; C M Hobday; G P Haffenden; C E Griffiths; A V Powles; P Wright; L Fry
Journal:  Br J Dermatol       Date:  1988-02       Impact factor: 9.302

10.  Immunosuppressive therapy in ocular cicatricial pemphigoid.

Authors:  B J Mondino; S I Brown
Journal:  Am J Ophthalmol       Date:  1983-10       Impact factor: 5.258

View more
  18 in total

Review 1.  Autoimmune bullous diseases: ocular manifestations and management.

Authors:  Caroline Laforest; Shyamala C Huilgol; Robert Casson; Dinesh Selva; Igal Leibovitch
Journal:  Drugs       Date:  2005       Impact factor: 9.546

2.  Coexistence of ocular cicatricial pemphigoid with Stevens Johnson syndrome.

Authors:  Hande Taylan Sekeroglu; Firas Simsek; Elif Erdem; Ibrahim Inan Harbiyeli; Meltem Yagmur; Reha Ersoz
Journal:  Int J Ophthalmol       Date:  2013-06-18       Impact factor: 1.779

Review 3.  Ocular mucous membrane pemphigoid: a review.

Authors:  Samanta Taurone; Marialuisa Spoletini; Massimo Ralli; Pietro Gobbi; Marco Artico; Laszlò Imre; Cecília Czakò; Illés Kovàcs; Antonio Greco; Alessandra Micera
Journal:  Immunol Res       Date:  2019-06       Impact factor: 2.829

4.  Incidence, clinical features and diagnosis of cicatrising conjunctivitis in Australia and New Zealand.

Authors:  Samantha Bobba; Connor Devlin; Nick Di Girolamo; Denis Wakefield; Peter McCluskey; Elsie Chan; Mark Daniell; Stephanie Watson
Journal:  Eye (Lond)       Date:  2018-06-19       Impact factor: 3.775

Review 5.  The 2016 Bowman Lecture Conjunctival curses: scarring conjunctivitis 30 years on.

Authors:  J K Dart
Journal:  Eye (Lond)       Date:  2017-01-20       Impact factor: 3.775

Review 6.  [Mucous membrane pemphigoid with ocular involvement. Part II: therapy].

Authors:  T Meyer-ter-Vehn; E Schmidt; D Zillikens; G Geerling
Journal:  Ophthalmologe       Date:  2008-04       Impact factor: 1.059

7.  Incidence, presenting features, and diagnosis of cicatrising conjunctivitis in the United Kingdom.

Authors:  C F Radford; S Rauz; G P Williams; V P J Saw; J K G Dart
Journal:  Eye (Lond)       Date:  2012-06-22       Impact factor: 3.775

Review 8.  Ocular cicatricial pemphigoid: manifestations and management.

Authors:  John H Chang; Peter J McCluskey
Journal:  Curr Allergy Asthma Rep       Date:  2005-07       Impact factor: 4.919

9.  Validation of a fornix depth measurer: a putative tool for the assessment of progressive cicatrising conjunctivitis.

Authors:  Geraint P Williams; Valerie P J Saw; Tariq Saeed; Simon T Evans; Paul Cottrell; S John Curnow; Peter Nightingale; Saaeha Rauz
Journal:  Br J Ophthalmol       Date:  2010-10-17       Impact factor: 4.638

Review 10.  [Mucous membrane pemphigoid with ocular involvement. Part I: Clinical manifestations, pathogenesis and diagnosis].

Authors:  E Schmidt; T Meyer-Ter-Vehn; D Zillikens; G Geerling
Journal:  Ophthalmologe       Date:  2008-03       Impact factor: 1.174

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.